vs

Side-by-side financial comparison of BED BATH & BEYOND, INC. (BBBY) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $247.8M, roughly 3.0× BED BATH & BEYOND, INC.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -6.6%, a 10.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 6.9%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -21.1%).

Bed Bath & Beyond was an American big-box retail chain specializing in housewares, furniture, and specialty items. Headquartered in Union, New Jersey, the chain operated stores in the United States and Canada, and was once counted among the Fortune 500 and the Forbes Global 2000. The chain filed for Chapter 11 bankruptcy in April 2023 and liquidated all of its remaining stores, with the last closing on July 30, 2023. Following the retail chain's liquidation, its name was adopted by online ret...

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BBBY vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
3.0× larger
CLOV
$749.2M
$247.8M
BBBY
Growing faster (revenue YoY)
CLOV
CLOV
+55.1% gap
CLOV
62.0%
6.9%
BBBY
Higher net margin
CLOV
CLOV
10.3% more per $
CLOV
3.6%
-6.6%
BBBY
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-21.1%
BBBY

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BBBY
BBBY
CLOV
CLOV
Revenue
$247.8M
$749.2M
Net Profit
$-16.4M
$27.3M
Gross Margin
23.9%
Operating Margin
68.8%
3.6%
Net Margin
-6.6%
3.6%
Revenue YoY
6.9%
62.0%
Net Profit YoY
58.9%
EPS (diluted)
$-0.24
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBBY
BBBY
CLOV
CLOV
Q1 26
$247.8M
$749.2M
Q4 25
$273.4M
$487.7M
Q3 25
$257.2M
$496.6M
Q2 25
$282.3M
$477.6M
Q1 25
$231.7M
$462.3M
Q4 24
$303.2M
$337.0M
Q3 24
$311.4M
$331.0M
Q2 24
$398.1M
$356.3M
Net Profit
BBBY
BBBY
CLOV
CLOV
Q1 26
$-16.4M
$27.3M
Q4 25
$-20.9M
$-49.3M
Q3 25
$-4.5M
$-24.4M
Q2 25
$-19.3M
$-10.6M
Q1 25
$-39.9M
$-1.3M
Q4 24
$-81.3M
$-22.1M
Q3 24
$-61.0M
$-9.2M
Q2 24
$-42.6M
$7.4M
Gross Margin
BBBY
BBBY
CLOV
CLOV
Q1 26
23.9%
Q4 25
24.6%
Q3 25
25.3%
Q2 25
23.7%
Q1 25
25.1%
Q4 24
23.0%
Q3 24
21.2%
24.5%
Q2 24
20.1%
30.3%
Operating Margin
BBBY
BBBY
CLOV
CLOV
Q1 26
68.8%
3.6%
Q4 25
-4.8%
-10.1%
Q3 25
-4.8%
-4.9%
Q2 25
-4.4%
-2.2%
Q1 25
-10.0%
-0.3%
Q4 24
-11.3%
-6.4%
Q3 24
-14.5%
-2.7%
Q2 24
-11.8%
2.0%
Net Margin
BBBY
BBBY
CLOV
CLOV
Q1 26
-6.6%
3.6%
Q4 25
-7.6%
-10.1%
Q3 25
-1.8%
-4.9%
Q2 25
-6.8%
-2.2%
Q1 25
-17.2%
-0.3%
Q4 24
-26.8%
-6.6%
Q3 24
-19.6%
-2.8%
Q2 24
-10.7%
2.1%
EPS (diluted)
BBBY
BBBY
CLOV
CLOV
Q1 26
$-0.24
$0.05
Q4 25
$-0.26
Q3 25
$-0.07
Q2 25
$-0.34
Q1 25
$-0.74
Q4 24
$-1.68
Q3 24
$-1.33
Q2 24
$-0.93

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBBY
BBBY
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$135.8M
$177.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$202.5M
$339.4M
Total Assets
$404.5M
$697.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBBY
BBBY
CLOV
CLOV
Q1 26
$135.8M
$177.6M
Q4 25
$175.3M
$78.3M
Q3 25
$167.4M
Q2 25
$120.6M
Q1 25
$114.6M
Q4 24
$159.2M
$194.5M
Q3 24
$140.4M
$288.0M
Q2 24
$186.2M
$254.8M
Stockholders' Equity
BBBY
BBBY
CLOV
CLOV
Q1 26
$202.5M
$339.4M
Q4 25
$217.6M
$308.7M
Q3 25
$202.6M
$340.9M
Q2 25
$130.9M
$344.2M
Q1 25
$143.4M
$336.1M
Q4 24
$162.7M
$341.1M
Q3 24
$196.2M
$342.2M
Q2 24
$250.4M
$324.9M
Total Assets
BBBY
BBBY
CLOV
CLOV
Q1 26
$404.5M
$697.7M
Q4 25
$425.5M
$541.0M
Q3 25
$414.4M
$559.7M
Q2 25
$358.1M
$575.0M
Q1 25
$363.7M
$583.7M
Q4 24
$402.0M
$580.7M
Q3 24
$428.3M
$653.0M
Q2 24
$496.8M
$674.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBBY
BBBY
CLOV
CLOV
Operating Cash FlowLast quarter
$-11.8M
Free Cash FlowOCF − Capex
$-12.8M
FCF MarginFCF / Revenue
-5.2%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBBY
BBBY
CLOV
CLOV
Q1 26
$-11.8M
Q4 25
$-6.5M
$-66.9M
Q3 25
$-15.1M
$12.1M
Q2 25
$15.8M
$5.4M
Q1 25
$-50.9M
$-16.3M
Q4 24
$-21.7M
$34.8M
Q3 24
$-42.1M
$50.0M
Q2 24
$-75.9M
$44.8M
Free Cash Flow
BBBY
BBBY
CLOV
CLOV
Q1 26
$-12.8M
Q4 25
$-8.6M
$-69.0M
Q3 25
$-17.4M
$11.4M
Q2 25
$14.0M
$4.8M
Q1 25
$-52.1M
$-16.5M
Q4 24
$-24.7M
$33.3M
Q3 24
$-45.5M
$49.6M
Q2 24
$-80.4M
$44.4M
FCF Margin
BBBY
BBBY
CLOV
CLOV
Q1 26
-5.2%
Q4 25
-3.2%
-14.1%
Q3 25
-6.8%
2.3%
Q2 25
5.0%
1.0%
Q1 25
-22.5%
-3.6%
Q4 24
-8.1%
9.9%
Q3 24
-14.6%
15.0%
Q2 24
-20.2%
12.5%
Capex Intensity
BBBY
BBBY
CLOV
CLOV
Q1 26
Q4 25
0.8%
0.4%
Q3 25
0.9%
0.1%
Q2 25
0.6%
0.1%
Q1 25
0.5%
0.0%
Q4 24
1.0%
0.5%
Q3 24
1.1%
0.1%
Q2 24
1.1%
0.1%
Cash Conversion
BBBY
BBBY
CLOV
CLOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons